{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:43Z","timestamp":1793289583626,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774061"],"award-info":[{"award-number":["81774061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873076"],"award-info":[{"award-number":["81873076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113341","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T12:30:31Z","timestamp":1656678631000},"page":"113341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases"],"prefix":"10.1016","volume":"153","author":[{"given":"Hongyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113341_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/intimm\/dxz037","article-title":"Sphingosine 1-phosphate and inflammation","volume":"31","author":"Obinata","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0022034510389178","article-title":"Dissecting the role of the S1P\/S1PR axis in health and disease","volume":"90","author":"Aarthi","year":"2011","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.biopha.2022.113341_bib3","first-page":"366","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113341_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/14712598.2020.1732919","article-title":"Modulation of sphingosine-1-phosphate in ulcerative colitis","volume":"20","author":"Argollo","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.biopha.2022.113341_bib5","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1194\/jlr.R046300","article-title":"An update on the biology of sphingosine 1-phosphate receptors","volume":"55","author":"Blaho","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1933\u20131947","key":"10.1016\/j.biopha.2022.113341_bib6","article-title":"Illuminating G-protein-coupling selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113341_bib7","doi-asserted-by":"crossref","first-page":"eabn0067","DOI":"10.1126\/sciadv.abn0067","article-title":"Structure of S1PR2-heterotrimeric G13 signaling complex","volume":"8","author":"Chen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.113341_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","article-title":"Sphingosine-1-phosphate and its receptors: structure, signaling, and influence","volume":"82","author":"Rosen","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2022.113341_bib9","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1074\/jbc.M609648200","article-title":"Identification of the hydrophobic ligand binding pocket of the S1P1 receptor","volume":"282","author":"Fujiwara","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113341_bib10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41422-021-00566-x","article-title":"Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition","volume":"31","author":"Yuan","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.113341_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ebiom.2018.12.038","article-title":"S1P\/S1PR3 axis promotes aerobic glycolysis by YAP\/c-MYC\/PGAM1 axis in osteosarcoma","volume":"40","author":"Shen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2022.113341_bib12","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1084\/jem.20160392","article-title":"S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3\/IL-1beta","volume":"214","author":"Weichand","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113341_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCRESAHA.120.318412","article-title":"Programming to S1PR1(+) endothelial cells promotes restoration of vascular integrity","volume":"129","author":"Akhter","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.113341_bib14","article-title":"Post-translational modifications of S1PR1 and endothelial barrier regulation","volume":"1865","author":"Anwar","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.biopha.2022.113341_bib15","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.2147\/CMAR.S237330","article-title":"S1PR2 knockdown promotes migration and invasion in multiple myeloma cells via NF-kappaB activation","volume":"12","author":"Pang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2022.113341_bib16","article-title":"S1PR2 inhibition attenuates allergic asthma possibly by regulating autophagy","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113341_bib17","first-page":"106","article-title":"[Effect of S1PR2 inhibition on epithelial ovarian cancer SKOV3 cell proliferation in vitro and in vivo]","volume":"53","author":"Dai","year":"2018","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.biopha.2022.113341_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1164\/rccm.201708-1726ED","article-title":"The role of S1PR3 in protection from bacterial sepsis","volume":"196","author":"Shea","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2022.113341_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2643-3230.BCD-20-0200","article-title":"Function of sphingolipid signaling via S1PR3 in hematopoietic and leukemic","volume":"2","author":"Yang","year":"2021","journal-title":"Stem Cells Blood Cancer Discov."},{"key":"10.1016\/j.biopha.2022.113341_bib20","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1172\/JCI136928","article-title":"S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion","volume":"130","author":"Olesch","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113341_bib21","doi-asserted-by":"crossref","first-page":"6059203","DOI":"10.1155\/2017\/6059203","article-title":"Beyond immune cell migration: the emerging role of the sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation","volume":"2017","author":"Olesch","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113341_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","article-title":"Sphingosine 1-phosphate receptor modulator therapy for multiple sclerosis: differential downstream receptor signalling and clinical profile effects","volume":"81","author":"Chun","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2022.113341_bib23","series-title":"Cancers","first-page":"14","article-title":"Sphingosine 1-Phosphate Receptor 5 (S1P5) deficiency promotes proliferation and immortalization of mouse embryonic fibroblasts","author":"Talmont","year":"2022"},{"key":"10.1016\/j.biopha.2022.113341_bib24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fphys.2013.00338","article-title":"Sphingosine 1-phosphate axis: a new leader actor in skeletal muscle biology","volume":"4","author":"Donati","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2022.113341_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbamcr.2011.11.016","article-title":"Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors","volume":"1823","author":"Calise","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113341_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ydbio.2013.07.006","article-title":"Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells","volume":"382","author":"Fortier","year":"2013","journal-title":"Dev. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1126\/science.2414846","article-title":"Plasticity of the differentiated state","volume":"230","author":"Blau","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113341_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/978-3-7091-1511-4_23","article-title":"Role of sphingosine 1-phosphate in skeletal muscle cell biology","author":"Bruni","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113341_bib29","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","article-title":"Sphingosine-1-phosphate receptors in the central nervous and immune systems","volume":"17","author":"Healy","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2022.113341_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-7091-1511-4_1","article-title":"Sphingosine kinase\/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance","author":"Selvam","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113341_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9597-4_1","article-title":"Introduction to the immune system","volume":"2024","author":"McComb","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib32","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113341_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1115-8_1","article-title":"A brief outline of the immune system","volume":"1184","author":"Tomar","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-57613-8_1","article-title":"The role of the immune system beyond the fight against infection","volume":"1003","author":"Sattler","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmcl.2016.11.050","article-title":"A benzo[b]thiophene-based selective type 4 S1P receptor agonist","volume":"27","author":"Hur","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.113341_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00281-019-00765-0","article-title":"Resolution of inflammation during multiple sclerosis","volume":"41","author":"Ruiz","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.biopha.2022.113341_bib37","first-page":"8","article-title":"Sphingosine-1-phosphate: its pharmacological regulation and the treatment of multiple sclerosis: a review article","author":"Cohan","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2022.113341_bib38","article-title":"Sphingosine 1-phosphate receptor modulator therapy for multiple sclerosis: differential downstream receptor signalling and clinical profile effects","author":"Chun","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2022.113341_bib39","first-page":"10","article-title":"Signaling through the S1P-S1PR axis in the gut, the immune and the central nervous system in multiple sclerosis: implication for pathogenesis and treatment","author":"Chatzikonstantinou","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113341_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s13311-017-0565-4","article-title":"Sphingosine 1-phosphate receptor modulators for the treatment of multiple sclerosis","volume":"14","author":"Chaudhry","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2022.113341_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/2040622315617354","article-title":"Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases","volume":"7","author":"D\u2019Ambrosio","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.biopha.2022.113341_bib42","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-022-06094-9","article-title":"[18F]FDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis: a systematic review","author":"Nabizadeh","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2022.113341_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2022.04.027","article-title":"A systematic review and quantitative synthesis of the long-term psychiatric sequelae of pediatric autoimmune encephalitis","volume":"308","author":"Nguyen","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2022.113341_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.822919","article-title":"TH cells and cytokines in encephalitogenic disorders","volume":"13","author":"Krishnarajah","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib45","doi-asserted-by":"crossref","first-page":"eabl6157","DOI":"10.1126\/scitranslmed.abl6157","article-title":"Tissue-resident CD8(+) T cells drive compartmentalized and chronic autoimmune damage against CNS neurons","volume":"14","author":"Frieser","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"31","key":"10.1016\/j.biopha.2022.113341_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8380","article-title":"Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation","volume":"4","author":"Mundt","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib47","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4049\/jimmunol.1801683","article-title":"Reduced annexin A1 expression associates with disease severity and inflammation in multiple sclerosis patients","volume":"203","author":"Colamatteo","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/imm.12272","article-title":"Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond","volume":"142","author":"Garris","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2022.113341_bib49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1248\/yakushi.129.655","article-title":"[New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)]","volume":"129","author":"Chiba","year":"2009","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.biopha.2022.113341_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib51","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1113640","article-title":"Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients","volume":"309","author":"Schwab","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113341_bib52","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib53","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni.1743","article-title":"The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR","volume":"10","author":"Liu","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nature02238","article-title":"T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases","volume":"427","author":"Mempel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113341_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib56","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2250","article-title":"STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors","volume":"16","author":"Lee","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.113341_bib57","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ni.2730","article-title":"Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation","volume":"14","author":"Garris","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib58","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.4049\/jimmunol.178.11.6806","article-title":"Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice","volume":"178","author":"Huang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib59","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.4049\/jimmunol.178.9.5425","article-title":"Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphate","volume":"178","author":"Liao","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib60","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib61","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2022.113341_bib62","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.113341_bib63","doi-asserted-by":"crossref","DOI":"10.1177\/10781552221096165","article-title":"New and emerging therapies for the treatment of relapsed\/refractory diffuse large B-cell lymphoma","author":"Moore","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.biopha.2022.113341_bib64","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: results from two prospective Korean cohorts","author":"Yi","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2022.113341_bib65","article-title":"Diffuse large B-cell lymphoma promotes endothelial-to-mesenchymal transition via WNT10A\/Beta-Catenin\/Snail signaling","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113341_bib66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/aje\/kwu290","article-title":"Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci","volume":"181","author":"Wang","year":"2015","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.biopha.2022.113341_bib67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.biopha.2022.113341_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-3532-1_1","article-title":"B cell development and maturation","volume":"1254","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri.2017.24","article-title":"Altered B cell signalling in autoimmunity","volume":"17","author":"Rawlings","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib70","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1084\/jem.20061041","article-title":"Regulation of B1 cell migration by signals through Toll-like receptors","volume":"203","author":"Ha","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113341_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073465","article-title":"Sphingosine-1-Phosphate Receptor Type 4 (S1P4) is differentially regulated in peritoneal B1 B cells upon TLR4 stimulation and facilitates the egress of peritoneal B1a B cells and subsequent accumulation of Splenic IRA B cells under inflammatory conditions","volume":"22","author":"Riese","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113341_bib72","first-page":"22","article-title":"Early covert appearance of marginal zone B cells in salivary glands of Sj\u00f6gren\u2019s syndrome-susceptible mice: initiators of subsequent overt clinical disease","author":"Peck","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113341_bib73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fimmu.2017.00378","article-title":"Sphingolipids are dual specific drug targets for the management of pulmonary infections: perspective","volume":"8","author":"Sharma","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fimmu.2017.00296","article-title":"Sphingosine 1-phosphate: a novel target for lung disorders","volume":"8","author":"Mohammed","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib75","doi-asserted-by":"crossref","first-page":"15025","DOI":"10.1038\/nrdp.2015.25","article-title":"Asthma","volume":"1","author":"Holgate","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2022.113341_bib76","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fcell.2020.00444","article-title":"Decoding the role of Sphingosine-1-phosphate in asthma and other respiratory system diseases using next generation knowledge discovery platforms coupled with luminex multiple analyte profiling technology","volume":"8","author":"Bahlas","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib77","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1182\/blood-2007-09-115451","article-title":"Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions","volume":"111","author":"Oskeritzian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113341_bib78","first-page":"1619","article-title":"Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells","volume":"40","author":"Hsu","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2022.113341_bib79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrs.2010.05.005","article-title":"Downregulation of sphingosine-1-phosphate receptors in bronchial smooth muscle of mouse experimental asthma","volume":"62","author":"Chiba","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.113341_bib80","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1165\/rcmb.2009-0223OC","article-title":"Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung","volume":"43","author":"Sammani","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib81","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/380634a0","article-title":"Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor","volume":"380","author":"Choi","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2022.113341_bib82","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020905521","article-title":"Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers","volume":"10","author":"Camp","year":"2020","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.biopha.2022.113341_bib83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21037\/atm-21-6679","article-title":"Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling","volume":"10","author":"Wang","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.biopha.2022.113341_bib84","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.113341_bib85","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2006.01.036","article-title":"The bone marrow functionally contributes to liver fibrosis","volume":"130","author":"Russo","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.113341_bib86","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3389\/fimmu.2020.01149","article-title":"Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib87","doi-asserted-by":"crossref","first-page":"13423","DOI":"10.1038\/srep13423","article-title":"Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte\/macrophage motility in cholestatic liver injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113341_bib88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajpath.2012.03.014","article-title":"Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-\u03b21 via sphingosine kinase\/sphingosine 1-phosphate (S1P)\/S1P receptor axis","volume":"181","author":"Yang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2022.113341_bib89","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jhep.2009.01.028","article-title":"Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis","volume":"50","author":"Li","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.113341_bib90","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.omtn.2019.02.014","article-title":"MicroRNA-26b-5p inhibits mouse liver fibrogenesis and angiogenesis by targeting PDGF receptor-beta","volume":"16","author":"Yang","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2022.113341_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-020-2582-1","article-title":"Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113341_bib92","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113341_bib93","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbamcr.2007.11.008","article-title":"Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures","volume":"1783","author":"Brunati","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113341_bib94","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/jcp.22572","article-title":"Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation","volume":"226","author":"Liu","year":"2011","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113341_bib95","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2013.02.021","article-title":"Sphingosine kinase\/sphingosine 1-phosphate (S1P)\/S1P receptor axis is involved in liver fibrosis-associated angiogenesis","volume":"59","author":"Yang","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.113341_bib96","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.31321","article-title":"Inhibition of Sphingosine-1-phosphate-induced Th17 cells ameliorates alcohol-associated steatohepatitis in mice","volume":"73","author":"Chu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113341_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-018-0860-y","article-title":"Co-stimulation of LPAR1 and S1PR1\/3increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases","author":"Li","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2022.113341_bib98","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14728222.2016.1103735","article-title":"Therapeutic targets for cholestatic liver injury","volume":"20","author":"Woolbright","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2022.113341_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5582\/bst.2018.01247","article-title":"Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury","volume":"13","author":"Zhang","year":"2019","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.biopha.2022.113341_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110119","article-title":"Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration","volume":"9","author":"Bradley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113341_bib101","doi-asserted-by":"crossref","first-page":"ra58","DOI":"10.1126\/scisignal.aaa4998","article-title":"Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation","volume":"8","author":"Panneer Selvam","year":"2015","journal-title":"Sci. Signal"},{"key":"10.1016\/j.biopha.2022.113341_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2022.113341_bib103","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.18632\/oncotarget.24583","article-title":"Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113341_bib104","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3892\/ol.2020.12071","article-title":"Potential biomarkers Ang II\/AT1R and S1P\/S1PR1 predict the prognosis of hepatocellular carcinoma","volume":"20","author":"Ji","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2022.113341_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209050","article-title":"Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2","volume":"13","author":"Matsushima-Nishiwaki","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113341_bib106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jss.2020.11.044","article-title":"Sphingosine-1-phosphate receptor-1 promotes vascular invasion and EMT in hepatocellular carcinoma","volume":"259","author":"Yokota","year":"2020","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113341_bib107","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/cancers13020311","article-title":"Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic Target","volume":"13","author":"Cortini","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.biopha.2022.113341_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055255","article-title":"Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism","volume":"8","author":"Finley","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113341_bib109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2011.05.018","article-title":"Sphingosine-1-phosphate acting via the S1P(1) receptor is a downstream signaling pathway in ceramide-induced hyperalgesia","volume":"499","author":"Doyle","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2022.113341_bib110","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.joca.2021.06.001","article-title":"Inhibition of sphingosine 1-phosphate protects mice against chondrocyte catabolism and osteoarthritis","volume":"29","author":"Cherifi","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2022.113341_bib111","doi-asserted-by":"crossref","first-page":"C428","DOI":"10.1152\/ajpcell.00148.2016","article-title":"Shear stress induces Galphaq\/11 activation independently of G protein-coupled receptor activation in endothelial cells","volume":"312","author":"Dela Paz","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113341_bib112","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/cvr\/cvn118","article-title":"G12\/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase","volume":"79","author":"Takashima","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.113341_bib113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00109-020-02032-4","article-title":"NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate\/S1P receptor 2\/Galpha(12\/13)\/MAPK signaling pathway","volume":"99","author":"Hou","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113341_bib114","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/onc.2011.396","article-title":"Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models","volume":"31","author":"Harma","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.113341_bib115","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101531R","article-title":"Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1 -selective modulation","volume":"36","author":"Kihara","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2022.113341_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639650","article-title":"Immunomodulation eliminates inflammation in the hippocampus in experimental autoimmune encephalomyelitis, but does not ameliorate anxiety-like behavior","volume":"12","author":"Kocovski","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib117","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","article-title":"Lysophospholipids and their receptors in the central nervous system","volume":"1831","author":"Choi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113341_bib118","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113341_bib119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-030-35582-1_7","article-title":"S1P signaling in the tumor microenvironment","volume":"1223","author":"Schneider","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222098","article-title":"Expression of sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 in malaria-associated acute lung injury\/acute respiratory distress syndrome in a mouse model","volume":"14","author":"Punsawad","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113341_bib121","doi-asserted-by":"crossref","first-page":"3932569","DOI":"10.1155\/2020\/3932569","article-title":"Overexpression of sphingosine kinase-1 and sphingosine-1-phosphate receptor-3 in severe Plasmodium falciparum malaria with pulmonary edema","volume":"2020","author":"Viriyavejakul","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2022.113341_bib122","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2021.12.002","article-title":"Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome","volume":"13","author":"Hong","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.113341_bib123","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3389\/fimmu.2020.01149","article-title":"Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113341_bib124","first-page":"112","article-title":"Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy","author":"Kawai","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113341_bib125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bcp.2019.04.018","article-title":"Telmisartan and\/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: implications of cross-talk between angiotensin, the sphingosine kinase\/sphingoine-1-phosphate pathway, and TLR4 receptors","volume":"164","author":"Alqarni","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113341_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.760638","article-title":"Sphingolipids in lung pathology in the coronavirus disease era: a review of sphingolipid involvement in the pathogenesis of lung damage","volume":"12","author":"Khan","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2022.113341_bib127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1139\/bcb-2016-0025","article-title":"FTY720P inhibits hepatic Na(+)-K(+) ATPase via S1PR2 and PGE2","volume":"94","author":"Al Alam","year":"2016","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113341_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27835","article-title":"Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcoma","volume":"66","author":"Morrell","year":"2019","journal-title":"Pediatr. Blood Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222007302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222007302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:35:06Z","timestamp":1779968106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222007302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":128,"alternative-id":["S0753332222007302"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113341","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113341"}}